SCHEMBL21922609

SCHEMBL21922609

N#Cc1ccc(-c2ccc(-c3cccc(C4(c5cccc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)c5)c5ccccc5-c5ccccc54)c3)c3ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 6/20 0.41
▸ CYP3A4 P08684 5/20 0.41
▸ MEN1 O00255 4/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ LMNA P02545 4/20 0.41
▸ CYP2C19 P33261 3/20 0.41
▸ CLK4 Q9HAZ1 3/20 0.41
▸ HSD17B10 Q99714 3/20 0.41
▸ CYP2D6 P10635 3/20 0.41
▸ TSHR P16473 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ ABCG2 Q9UNQ0 11/20 0.40
▸ ABCB1 P08183 5/20 0.40
▸ PDK2 Q15119 2/20 0.40
▸ MAPK1 P28482 2/20 0.38
▸ TP53 P04637 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ ADORA2A P29274 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20691427 0.94 ABCG2 (0.41) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL21922798 0.93 ABCG2 (0.43) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL20959730 0.91 ABCG2 (0.43) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL30943702 0.91 ABCG2 (0.43) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL20999534 0.91 PDK2 (0.45) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL21922604 0.91 PDK2 (0.45) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL21922494 0.90 PDK2 (0.44) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL21922607 0.90 PDK2 (0.44) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL21922613 0.90 ABCG2 (0.43) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL21922608 0.90 PDK2 (0.46) CYP1A2CYP3A4MEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542237-B2 Fluorene derivative and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-01-03 — — US disclosed
US-20200131138-A1 FLUORENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11542237-B2 Fluorene derivative and organic light emitting device comprising same CRY1, CRY2, LEF1 CYP1A2 19/4885CYP3A4 38/4885MEN1 356/4885
US-20200131138-A1 FLUORENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CRY2, LEF1 CYP1A2 19/4885CYP3A4 38/4885MEN1 356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback